Symbol="KDNY"
AssetType="Common Stock"
Name="Chinook Therapeutics Inc"
Description="Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision drugs for kidney disease. The company is headquartered in Seattle, Washington."
CIK="1435049"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="740 HEINZ AVENUE, BERKELEY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="2702095000"
EBITDA="-197027008"
PERatio="None"
PEGRatio="None"
BookValue="6.17"
DividendPerShare="0"
DividendYield="0"
EPS="-3.24"
RevenuePerShareTTM="0.078"
ProfitMargin="0"
OperatingMarginTTM="-38.44"
ReturnOnAssetsTTM="-0.235"
ReturnOnEquityTTM="-0.516"
RevenueTTM="5259000"
GrossProfitTTM="-135083000"
DilutedEPSTTM="-3.24"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.322"
AnalystTargetPrice="40.3"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="27.9"
PriceToBookRatio="3.057"
EVToRevenue="19.67"
EVToEBITDA="-11.5"
Beta="0.673"
num_52WeekHigh="40.51"
num_52WeekLow="18.34"
num_50DayMovingAverage="36.38"
num_200DayMovingAverage="26.27"
SharesOutstanding="67050000"
DividendDate="2020-10-02"
ExDividendDate="None"
symbol="KDNY"
open="40.31"
high="40.51"
low="40.30"
price="40.39"
volume="4924994.00"
latest_trading_day="2023-08-10"
previous_close="40.30"
change="0.09"
change_percent="0.2233%"
aroon_positive_momentum_days="50"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Trending Low"
value_analysis="Bearish Trend"
Aroon_change="FALSE"
Aroon_momentum="50"
Volume_recent_avg="1509374"
Change_recent_avg="0.02"
Delta_recent_avg="0.73"
Variance_recent_avg="0.37"
Change_ratio_recent_avg="0.05"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="50"
Aroon_momentum_negative="50"
image_negative_thumbnail_id_1="1120"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0153.jpeg"
image_negative_thumbnail_id_2="500"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0105.jpeg"
image_neutral_thumbnail_id_1="578"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0021.jpeg"
image_neutral_thumbnail_id_2="536"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0063.jpeg"
image_positive_thumbnail_id_1="687"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0021.jpeg"
image_positive_thumbnail_id_2="615"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0093.jpeg"
image_professor_thumbnail_id_1="1173"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
image_professor_thumbnail_id_2="1188"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
